Dr. Shadi Ghadermarzi, MD

Dr. Ghadermarzi practices at VCU Health Tappahannock Hospital in Tappahannock, Virginia, part of Commonwealth of Virginia.

Dr. Ghadermarzi's NPI, 1073040226, was assigned on May 18, 2017. Dr. Ghadermarzi holds Virginia license 0101271541.

Dr. Ghadermarzi's primary practice is VCU Health Tappahannock Hospital, at 618 Hospital Road, Tappahannock, VA 22560 in Essex County. The practice phone is (804) 443-3311.

Dr. Ghadermarzi's primary practice is VCU Health Tappahannock Hospital in Tappahannock, Virginia, part of Commonwealth of Virginia. Dr. Ghadermarzi is also affiliated with VCU Medical Center. The medical group on file is MCV Physicians. Dmand AI also links Dr. Ghadermarzi to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ghadermarzi practices, 2 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Ghadermarzi's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dmand AI has Dr. Ghadermarzi's licenses on file in 2 states: Virginia and North Carolina.

CMS data shows 226 Medicare services from Dr. Ghadermarzi across 5 procedure codes in 2024, for 136 Medicare patients. Medicare paid $19,711 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 136 Medicare patients who saw Dr. Ghadermarzi in 2024. The largest group is 75 to 84, with 58 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ghadermarzi's median patient age at 71, with 48% women.

In 2024, Dr. Ghadermarzi wrote 178 Medicare Part D claims for 72 patients. 86% of them were for generic drugs. CMS names the drug for 32 of them, across 2 drugs with 11 or more claims each, at $245 in total drug cost. In 2023, CMS named 111 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Ghadermarzi for performance year 2024, reported as part of a group. Dr. Ghadermarzi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Dr. Ghadermarzi from 1 drug or device company in 2020. Food and beverage make up the largest share, 100% of the total. La Jolla Pharmaceutical Company paid the most, $24.